Is there a specific mutation of p53 gene due to radon exposure? A systematic review

References

• Ahrendt S A, Chow J T, Yang S C, Wu L, Zhang M J, Jen J, Sidransky D. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. Cancer Research 2000; 60: 3155–3159
   PubMed Web of Science ®Google Scholar
• Azzam E, Toledo S M, Little J B. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha-particle irradiated to non-irradiated cell. Proceedings of the National Academy of Sciences of the USA 2001; 98(2)473–478
   PubMed Web of Science ®Google Scholar
• Bartsch H, Hollstein M, Mustonen R, Schimdt J, Spiethoff A, Wesch H, Wiethege T, Müller K M. Screening for putative radon-specific p53 mutation hotspot in German uranium miners. The Lancet 1995; 346: 121
   PubMed Web of Science ®Google Scholar
• Bastide K, Guilly M N, Bernaudin J F, Joubert C, Lectard B, Levalois C, Malfoy B, Chevillard S. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors. Lung Cancer 2009; 63(3)348–353
   PubMed Web of Science ®Google Scholar
• Bennett W P, Hussain S P, Vähäkangas K H, Khan M A, Shields P G, Harris C C. Molecular epidemiology of human cancer risk: Gene-environment interactions and p53 mutation spectrum in human lung cancer. Journal of Pathology 1999; 187: 8–18
   PubMed Web of Science ®Google Scholar
• Evans H J, Prosser J. Tumor-supressor genes: Cardinal factors in inherited predisposition to human cancers. Environmental Health Perspectives 1992; 98: 25–37
   PubMed Web of Science ®Google Scholar
• Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, Harris C C, Montesano R. IARC database of p53 gene mutations in human tumors and cell lines: Updated compilation, revised formats and new visualization tools. Nucleic Acids Research 1998; 26: 205–213
   PubMed Web of Science ®Google Scholar
• Harris C C. P53 tumor supressor gene: At the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment. Environmental Health Persepectives 1996; 104(Suppl. 3)435–439
   PubMedGoogle Scholar
• Hei T K, Wu L J, Liu S X, Vannais D, Waldren C A. Mutagenic effects of a single particle and an exact number of alpha particles in mammalian cells. Proceedings of the National Academy of Sciences of the USA 1997; 94: 3765–3770
   PubMed Web of Science ®Google Scholar
• Hernandez-Boussard T M, Hainaut P. A specific spectrum of p53 mutations in lung cancer from smokers: Review of mutations compiled in the IARC p53 database. Environmental Health Perspectives 1998; 106(7)385–391
   PubMed Web of Science ®Google Scholar
• Hickman A W, Jaramillo R J, Lechner J F, Johnson N F. Alpha-particle-induced p53 protein expression in a rat lung epithelial cell strain. Cancer Research 1994; 54: 5797–5800
   PubMed Web of Science ®Google Scholar
• Hollstein M, Bartsch H, Wesch H, Kure E H, Mustonen R, Mülhbauer K R, Spiethoff A, Wegener K, Wiethege T, Müller K M. p53 gene mutation analysis in tumors of patients exposed to α-particles. Carcinogenesis 1997; 18(3)511–516
   PubMed Web of Science ®Google Scholar
• Hollstein M, Sidransky D, Vogelstein B, Harris C C. P53 Mutations in human cancers. Science 1991; 253: 49–53
   PubMed Web of Science ®Google Scholar
• Hussain S P, Harris C C. P53 mutation and load: The generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer. Mutation Research 1999; 428: 23–32
   PubMed Web of Science ®Google Scholar
• Hussain S P, Kennedy C H, Amstad P, Lui H, Lechner J F, Harris C C. Radon and lung cancer carcinogenesis: Mutability of p53 codons 249 and 250 to 238Pu alfa-particles in human bronchial epithelial cells. Carcinogenesis 1997; 18(1)121–125
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of carcinogenic risks to humans. Man-made minerals and radon. IARC, Lyon 1988; 43
   Google Scholar
• International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of carcinogenic risks to humans. Ionizing radiation, part 2: Some internally deposited radionuclides. IARC, Lyon 2001; 78
   Google Scholar
• Knöbel Y, Weise A, Osswald K, Schäferhenrich A, Richter K K, Claussen U, Pool-Zobel B L. Uranyl nitriloacetate, a stabilized salt of uranium, is genotoxic in nontransformed human colon cells and in the human colon adenoma cell line LT97. Toxicological Sciences 2006; 93(2)286–297
   PubMed Web of Science ®Google Scholar
• Lehnert B E, Goodwin E H. A new mechanism for DNA alterations induced by alpha particles such as those emitted by radon and radon progeny. Environmental Health Perspectives 1997; 105(5)1095–1099
   PubMedGoogle Scholar
• Levine A J, Momand J, Finlay C A. The p53 tumor supressor gene. Nature 1991; 351: 453–456
   PubMed Web of Science ®Google Scholar
• Li H, Gu Y, Miki J, Hukku B, McLeod D, Hei T, Rhim J S. Malignant transformation of human benign prostate epithelial cells by high linear energy transfer alfa-particles. International Journal of Oncology 2007; 31: 537–544
   PubMed Web of Science ®Google Scholar
• Lo Y M, Darby S, Noakes L, Whitley E, Silcocks P B, Fleming K A, Bell J I. Screening for codon 249 p53 mutation in lung cancer associated with domestic radon exposure. The Lancet 1995; 345: 60
   PubMed Web of Science ®Google Scholar
• Luque J, Herráez A. Biología Molecular e Ingeniería Genética. Harcourt, Madrid 2001
   Google Scholar
• McDonald J, Taylor J, Watson M, Saccomanno, Devereux T R. P53 and K-ras in radon-associated lung adenocarcinoma. Cancer Epidemiology, Biomarkers & Prevention 1995; 4(7)791–793
   PubMed Web of Science ®Google Scholar
• National Reserch Council (NRC). NRC committee on the biological effects of ionizing radiations. Health effects of exposure to radon (BEIR VI). National Academic Press, Washington, DC 1998
   Google Scholar
• Pfeifer G P, Denissenko M F, Olivier M, Trtyakova N, Hecht S S, Hainaut P. Tobaco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002; 21: 7435–7451
   PubMed Web of Science ®Google Scholar
• Popp W, Vahrenholz C, Schuster H, Wiesner B, Bauer P, Täuscher F, Plogmann H, Morgenroth K, Konietzko N, Norpoth K. p53 mutations and codon 213 polymorphism of p53 in lung cancers of former uranium miners. Journal of Cancer Research and Clinical Oncolology 1999; 125: 309–312
   PubMed Web of Science ®Google Scholar
• Rodin S N, Rodin A S. Human lung cancer and p53: The interplay between mutagenesis and selection. Proceedings of the National Academy of Sciences of the USA 2000; 97(22)12244–12249
   PubMed Web of Science ®Google Scholar
• Ruano-Ravina A, Pérez-Becerra R, Fraga M, Kelsey K T, Barros-Dios J M. Analysis of the relationship between p53 immunohistochemichal expression and risk factors for lung cancer, with special emphasis on residential radon exposure. Annals of Oncology 2008; 19: 109–114
   PubMed Web of Science ®Google Scholar
• Semenza J C, Wease L H. Molecular epidemiology in environmental health: The potential of tumor supressor gene p53 as a biomarker. Environmental Health Perspectives 1997; 105(Suppl. 1)155–163
   PubMedGoogle Scholar
• Szymanska K, Hainaut P. TP53 and mutations in human cancer. Acta Biochimica Polonica 2003; 50(1)231–238
   PubMed Web of Science ®Google Scholar
• Taylor J A, Watson M A, Deveraux T R, Michels R Y, Saccomanno G, Anderson M. P53 mutation hotspot in radon-associated lung cancer. The Lancet 1994; 343: 86–87
   PubMed Web of Science ®Google Scholar
• Toyooka S, Tsuda T, Gazdar A F. The TP53 gene, tobacco exposure and lung cancer. Human Mutation 2003; 21: 229–239
   PubMed Web of Science ®Google Scholar
• United States Environmental Protection Agency (USEPA). 2008, Accessed 4 June 2008 from the website: http://www.epa.gov/radon/index.html
   Google Scholar
• Vähäkangas K. TP 53 mutations in workers exposed to occupational carcinogens. Human Mutation 2003; 21: 240–251
   PubMed Web of Science ®Google Scholar
• Vähäkangas K H, Bennet W P, Castrén K, Weish J, Khan M A, Blömeke B, Alavanja M C, Harris C C. p53 and K-ras in lung cancers from former and never-smoking women. Cancer Research 2001; 4350–4356
   PubMed Web of Science ®Google Scholar
• Vähäkangas K H, Samet J M, Metcalf R A, Welsh J A, Bennett W P, Lane D P, Harris C C. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. The Lancet 1992; 339: 576–580
   PubMed Web of Science ®Google Scholar
• Venitt S, Biggs P J. Radon, mycotoxins, p53, and uranium mining. The Lancet 1994; 343: 795
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). 2008, Accessed 7 January 2009 from the website http://www.who.int/ionizing_radiation/env/radon/en/
   Google Scholar
• Yamada Y, Oghiso Y, Porlier J P, Guillet K, Fritsch P, Dudoignon N, Monchaux G. Comparative study on TP53 gene mutations in lung tumors from rats exposed to 239Pu, 237Np and 222Rn. Journal of Ratiation Research 2004; 45: 69–76
   Google Scholar
• Yang Q, Wesch H, Mueller K-M, Bartsch H, Wegener K, Hollstein M. Analysis of radon-associated squamous cell carcinomas of the lung for a p53 gene hotspot mutation. British Journal of Cancer 2000; 82(4)763–765
   PubMed Web of Science ®Google Scholar
• Yngveson A, Williams C, Hjerpe A, Lundeberg J, Söderkvist P, Pershagen G. P53 mutations in lung cancer associated with residential radon exposure. Cancer Epidemiology, Biomarkers & Prevention 1999; 8(5)433–438
   PubMed Web of Science ®Google Scholar
• Zhou H, Suzuki M, Randers-Pehrson G, Vannais D, Chen G, Trosko J E, Waldren C A, Hei T K. Radiation risk to low influences particles may be greater than we thought. Proceedings of the National Academy of Sciences of the USA 2001; 98(25)14410–14415
   PubMed Web of Science ®Google Scholar